Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TiaoBuFeiShen is a Traditional Chinese Medicine (TCM) herbal formula developed as a capsule for the treatment of chronic obstructive pulmonary disease (COPD). It is specifically indicated for use during the remission or stable period in patients diagnosed with "lung and kidney deficiency syndrome" according to TCM principles. Developed by the Second Affiliated Hospital of Tianjin University of TCM, the formula is designed to tonify the lungs and kidneys, improve respiratory function, and reduce the frequency and severity of acute exacerbations. As a botanical combination, it likely exerts its effects through multiple pathways, including anti-inflammatory and immunomodulatory actions, to stabilize the condition of patients with chronic airway obstruction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TiaoBuFeiShen.